Sino Medical Sciences Technology In (688108) — Capital Reinvestment Ratio
Latest as of September 2025:
0.21x
Sino Medical Sciences Technology In (688108) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.52 Million) in capital expenditures (CN¥6.63 Million). See 688108 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.21x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥31.52 Million
CNY
Capital Expenditures
CN¥6.63 Million
CNY
Data as of
Sep 2025
Most recent filing
Sino Medical Sciences Technology In Capital Reinvestment Ratio (2016–2025)
This chart tracks Sino Medical Sciences Technology In's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Sino Medical Sciences Technology In (2016–2025)
Year-by-year Capital Reinvestment Ratio for Sino Medical Sciences Technology In from 2016 to 2025. For live market cap and broader valuation context, see 688108 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥161.87 Million | CN¥45.80 Million | ▼ -47.0% |
| 2024 | 0.53x | CN¥131.24 Million | CN¥70.02 Million | ▼ -55.2% |
| 2023 | 1.19x | CN¥56.84 Million | CN¥67.67 Million | ▼ -25.6% |
| 2020 | 1.60x | CN¥70.51 Million | CN¥112.78 Million | ▲ +22.2% |
| 2019 | 1.31x | CN¥137.61 Million | CN¥180.04 Million | ▲ +29.1% |
| 2018 | 1.01x | CN¥97.56 Million | CN¥98.87 Million | ▼ -6.5% |
| 2017 | 1.08x | CN¥70.32 Million | CN¥76.25 Million | ▲ +3.3% |
| 2016 | 1.05x | CN¥42.24 Million | CN¥44.32 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow